-
Our Vision is to improve healthcare as a global provider of innovative and reliable diagnostic tests. -
Our Mission is to identify and develop novel patentable diagnostic markers and technologies which can be commercialised to meet clinical needs, both in the laboratory and at the point of care. -
We will collaborate with partners, create branded products and identify complementary businesses which support our objective of continuing to grow as a respected and profitable healthcare company. -
Our Values include meeting all current and future regulatory, quality and environmental standards appropriate for our industry and the countries in which we operate.
Senior Management Team
 |
David Bond CA David has a degree in Mathematics from Cambridge University, and qualified as a Chartered Accountant in 1996. He joined the group in his current role in 2008, and was appointed to the Senior Management Team in October 2010. Previously he has worked in finance roles in the Media sector, and before that for Ernst & Young in London and in Sydney. |
 |
Kjersti Grimsrud MSc, Biotechnology Kjersti has an MSc in Biotechnology. She has been with the company 22 years (since the start of Axis Biochemicals in Norway). Kjersti has held different positions ranging from research scientist, product manager, area manager, marketing director, commercial director and now holds the position Managing Director - PoC, based in Oslo. |
 |
Colin King MBA Colin has a business administration degree from the University of Abertay. He has 15 years' experience in operations management and has coordinated a number of large profile projects. Colin is an example of Axis-Shield's succession planning, having joined Axis- Shield 12 years ago. He has held various positions within the Laboratory Division’s management team culminating in his promotion during 2007 to site director. |
 |
Atle Schjøtt BA Atle has a Business Administration degree (Siviløkonom) from the University of Lund. He has held various positions, including controlling, marketing and administration within medical, pharmaceutical, dental and laboratory supply companies in Norway. He joined Medinor in 1996. |
 |
George Zajicek BPharm George is a pharmacist who previously worked for Unipath Limited and Boehringer Ingelheim. George is a founder member and ex-chairman of the UK In Vitro Diagnostics (IVD) Industry Trade Association, BIVDA, and a prominent figure in the European IVD industry. George joined the Group in 1989. He is charged with developing new business for Axis-Shield, particularly for OEM contracts with multinational organisations. |
Axis-Shield Directors and Senior Management
 |
John Brown PhD MBA FRSE Non-Executive Chairman |
 |
Erling M H Sundrehagen MD, MSc, PhD Chief Scientific Officer |
|
|
David Bond CA Group Financial Controller |
|
|
Kjersti Grimsrud MSc, Biotechnology Managing Director, Point-of-Care Division |
|
|
Colin King MBA Site Director, Laboratory Division |
|
|
George Zajicek BPharm, |
